Literature DB >> 28276007

Investigation on the association between thyroid tumorigeneses and herpesviruses.

J F M Almeida1, A H Campos2, M A Marcello1, N E Bufalo1, C L Rossi3, L H P Amaral1, A B Marques1, L L Cunha1, C A Alvarenga4, P C Tincani1, A J Tincani5, L S Ward6.   

Abstract

Herpesviruses have been associated with various human malignancies and with thyroid autoimmunity. Aiming to investigate the presence of these viruses in thyroid nodules, we analyzed serum and thyroid tissue from 183 patients (83 benign and 100 malignant thyroid nodules). We also obtained 104 normal thyroid tissues extracted from the contralateral lobe of these patients. We used ELISA to screen the serology of all patients and a real-time quantitative PCR to analyze thyroid tissue viral load in antibody-positive patients. In addition, the presence of herpesviruses was tested by histological analysis in 20 EBV-positive tissues using the expression of LMP-1 by immunohistochemistry (IHC) and EBER by in situ hybridization (ISH). There was no evidence of HSV-2 or CMV DNA, but we found EBV DNA sequences in 29 (16%) thyroid tissue samples. We also found 7 positive EBV cases out of 104 normal tissues. Viral load was higher in tumors than in their respective normal tissues (p = 0.0002). ISH analysis revealed EBER expression in 11 out of 20 (52%) EBV-positive tissues, mostly in malignant cases (8/11, 73%). The presence of high EBV copy numbers in thyroid tumors and the expression of EBER only in malignant cases suggest an association between EBV and thyroid malignancies. However, we did not find any association between the presence of EBV and/or its viral load and any clinical or pathological tumor feature. Further studies aiming to clarify the mechanisms of EBV infection in thyroid cells are necessary to support a possible role in the development of thyroid cancer.

Entities:  

Keywords:  Epstein–Barr virus infection; Herpesvirus; Thyroid cancer.; Thyroid nodules; Viral load

Mesh:

Substances:

Year:  2017        PMID: 28276007     DOI: 10.1007/s40618-017-0609-y

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  42 in total

1.  Laboratory markers of tumor burden in nasopharyngeal carcinoma: a comparison of viral load and serologic tests for Epstein-Barr virus.

Authors:  Hongxin Fan; John Nicholls; Daniel Chua; K H Chan; Jonathan Sham; Shuko Lee; Margaret L Gulley
Journal:  Int J Cancer       Date:  2004-12-20       Impact factor: 7.396

2.  On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis.

Authors:  Vey Hadinoto; Michael Shapiro; Thomas C Greenough; John L Sullivan; Katherine Luzuriaga; David A Thorley-Lawson
Journal:  Blood       Date:  2007-11-08       Impact factor: 22.113

3.  Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.

Authors:  Dewi K Paramita; Jajah Fachiroh; Wayan T Artama; Eric van Benthem; Sofia M Haryana; Jaap M Middeldorp
Journal:  J Med Virol       Date:  2007-11       Impact factor: 2.327

Review 4.  Serodiagnosis for tumor viruses.

Authors:  Brian J Morrison; Nazzarena Labo; Wendell J Miley; Denise Whitby
Journal:  Semin Oncol       Date:  2014-12-31       Impact factor: 4.929

5.  Expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): a clinicopathological study.

Authors:  Samuel Rosales-Pérez; Ana M Cano-Valdez; Christian H Flores-Balcázar; Ferran Guedea-Edo; Leonardo S Lino-Silva; Alicia Lozano-Borbalas; Arturo Navarro-Martín; Adela Poitevin-Chacón
Journal:  Arch Med Res       Date:  2014-03-04       Impact factor: 2.235

Review 6.  Epstein-Barr virus load monitoring: its role in the prevention and management of post-transplant lymphoproliferative disease.

Authors:  D T Rowe; S Webber; E M Schauer; J Reyes; M Green
Journal:  Transpl Infect Dis       Date:  2001-06       Impact factor: 2.228

7.  Herpesvirus type 7 infection may play an important role in individuals with a genetic profile of susceptibility to Graves' disease.

Authors:  Janaina Luisa Leite; Natassia Elena Bufalo; Roberto Bernardo Santos; João Hamilton Romaldini; Laura Sterian Ward
Journal:  Eur J Endocrinol       Date:  2009-11-10       Impact factor: 6.664

8.  Tracing of the molecular remnants of herpes virus infections in necrotic skin tissue.

Authors:  Takenobu Yamamoto; Akiko Yamada; Kazuhide Tsuji; Keiji Iwatsuki
Journal:  Eur J Dermatol       Date:  2008-08-08       Impact factor: 3.328

9.  Geographic variation in Epstein-Barr virus-associated Burkitt's lymphoma in children from Brazil.

Authors:  Claudete Esteves Klumb; Rocio Hassan; Deilson Elgui De Oliveira; Lídia Maria Magalhães De Resende; Maria Kadma Carriço; Jane De Almeida Dobbin; Maria S Pombo-De-Oliveira; Carlos E Bacchi; Raquel Ciuvalschi Maia
Journal:  Int J Cancer       Date:  2004-01-01       Impact factor: 7.396

Review 10.  Epstein Barr virus-associated lymphoproliferative diseases: the virus as a therapeutic target.

Authors:  Eric Tse; Yok-Lam Kwong
Journal:  Exp Mol Med       Date:  2015-01-23       Impact factor: 8.718

View more
  2 in total

1.  Epstein-Barr virus and thyroid cancer: the controversy remains.

Authors:  A Bychkov; S Keelawat
Journal:  J Endocrinol Invest       Date:  2017-05-30       Impact factor: 4.256

2.  Immune Cell Confrontation in the Papillary Thyroid Carcinoma Microenvironment.

Authors:  Zhenyu Xie; Xin Li; Yuzhen He; Song Wu; Shiyue Wang; Jianjian Sun; Yuchen He; Yu Lun; Jian Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-22       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.